[SYRE] YoY Quarter Result on 31-Dec-2023 [#Q4]

Stock
[SYRE] Spyre Therapeutics, Inc.
Announcement Date
29-Feb-2024
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- -57.53%
YoY- -235.67%
Quarter Report
SYRE's Result
SYRE's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 CAGR
Revenue 1,042 168 3,644 -46.52%
PBT -63,180 -18,784 -20,423 75.88%
Tax -5,746 38 23 -
NP -63,180 -18,822 -20,446 75.78%
Tax Rate - - - -
Total Cost 64,222 18,990 24,090 63.27%
Ratio Analysis
31/12/23 31/12/22 31/12/21 CAGR
NP Margin -6,063.34 -11,203.57 -561.09 228.73%
Per Share
31/12/23 31/12/22 31/12/21 CAGR
EPS -11.29 -7.20 -10.36 4.39%
EPS Diluted -11.29 -7.20 -10.36 4.39%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.